Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry, is further expanding its drug device combination products business by investing more than $50 million in a new Hemoteq AG production facility in Aachen, Germany, an important life science hotspot.
 
Freudenberg Medical grew its portfolio to include drug coating solutions for balloon catheters and stents as well as hydrophilic coatings when it acquired Hemoteq in 2015.
 
With this new facility, the company is not only expanding its capabilities but also reaffirming its roots in the region.

Tripling Its Manufacturing Footprint

The company will triple its manufacturing footprint with the new 130,000 sq. ft. facility in Alsdorf, located near the existing site. With its ISO Class 7 cleanrooms, laboratories, and offices it will serve as a hub for research, development, and production, driving innovation in medical coatings.
 
“The convergence of medical devices and drugs is inspiring a new generation of innovative products that fundamentally improve patients’ outcomes,” says Dr. Mark Ostwald, CEO of Freudenberg Medical. “With this innovation driven investment, we are strengthening our position as a strategic partner to our customers, offering vertically integrated solutions along the entire supply chain.”

Focus on Sustainability

The existing industrial building at the site is being converted to meet the highest medical technology as well as environmental and energy efficiency standards. A company-owned PV solar power plant will generate the energy needed to operate the site. Charging stations will enable emission-free commuting, energy recovery from the exhaust air of the clean rooms will be used for heating and an existing heavy oil tank will be converted into a cistern for rainwater utilization.
 
The first employees have been working at the new site since April 2024 in a development cleanroom adjacent to the main building. The site will be fully occupied by the end of 2026. Recruitment for the 150 additional positions in operations and R&D has already begun.
 
With a total area of 440,000 sq. ft., the site offers space for future expansion.